Table 1. Demographic and clinical characteristics of patients and their responses to treatment with SP and CQ.
Treatment with SP | Treatment with CQ | ||
Sex | Male | 66 | 66 |
Female | 34 | 34 | |
Male: Female | 1.94 | 1.94 | |
Age (years) | Mean ± S.D. | 20.69±13.0 | 21.74±13.84 |
Range | 2–64 | 2–65 | |
n (<15 years) | 34 | 33 | |
n (15–30 years) | 45 | 44 | |
n (>30 years) | 21 | 23 | |
Parasites count (µL−1) | Geometric mean | 19589.06 | 7678.79 |
Range | 3160–127720 | 1000–97866 | |
Proportion of patients with <50000 | 87 | 95 | |
Proportion of patients with >50000 | 13 | 5 |
ACPR = Adequate Clinical and Parasitological Response; TF = Treatment failure, ETF = Early Treatment Failure, LCF = Late Clinical Failure; LPF = Late Parasitological Failure; CF = Clinical failure, TF = Treatment failure.